Navigation Links
Vortex Biosciences Announces Publication in Nature Communications Describing the First Single Cell Western Blot for Circulating Tumor Cells
Date:3/23/2017

Vortex Biosciences, provider of circulating tumor cell (CTC) capture systems, today announced the publication of “Profiling protein expression in circulating tumor cells using microfluidic western blotting” in Nature Communications on March 23rd. The peer reviewed publication describes the use of the Vortex technology to capture CTCs and a microfluidic single-CTC resolution Western blot from Dr. Amy Herr’s team at the University of California, Berkeley to measure an 8-plex panel of cell surface and intracellular signaling proteins. Research conducted for this publication by Dr. Herr’s lab, in collaboration with Dr. Stefanie Jeffrey's lab at Stanford University, was funded by the National Institute of Health (NIH). Targeted proteomics with single-CTC resolution offers a unique analytical approach to understanding CTC biology.

CTC protein analyses primarily focus on surface and secreted proteins. While both proteomic factors are important, the capability to multiplex and assay a wide-range of protein targets (including intracellular signaling pathways) has been limited. In this paper, CTCs were first enriched using the Vortex system prior to introduction into a microfluidic single-CTC Western blot. The microfluidic design minimizes protein dilution and losses during targeted proteomics of single-CTCs for surface markers (EpCAM, CD45), oncoproteins (ER), oncogene signaling (ERK, eIF4E), cytokeratin (panCK), and housekeeping proteins (GAPDH, ß-Tubulin).

"We continue to work with great partners like Dr. Amy Herr at the University of California, Berkeley and Dr. Stefanie Jeffrey at Stanford University to try to find new ways to interrogate cancer biology,“ said Gene Walther, Chief Executive Officer of Vortex Biosciences. "Combining the high CTC recovery of the next generation Vortex technology with a single cell proteomics analytical platform provides a cutting edge approach for expanding our understanding of cancer biology."

The Vortex system utilizes a proprietary microfluidic chip to stably trap and capture CTCs in micro-scale vortices based on their larger size and greater deformability than the white and red blood cells. This unique approach to CTC isolation does not damage the proteins and results in CTCs that are high in purity making the Western blot assay workflow simple. Furthermore, CTCs are captured and collected unbiased by their molecular characteristics. Using this new approach, ER+ breast cancer patient-derived CTC analysis by Western blot reveals lower EpCAM and ER protein expression level variation than observed in an ER+ cell line. In the patient samples interrogated in this paper, both EpCAM-positive and EpCAM-negative CTCs were identified in a single patient sample. This new CTC single cell Western blot method established a capacity for retrospective, multiplexed CTC protein analyses.

The fully automated VTX-1 Liquid Biopsy System from Vortex represents the next step in CTC isolation. With a cancer cell recovery of 65-75%, best in class CTC purity, and collected CTCs being intact, viable, and ready for downstream analysis, the VTX-1 offers the best CTC samples available today.

About Vortex Biosciences
Vortex Biosciences is a cancer research and diagnostics company that integrates cancer biology, microfluidic engineering and informatics to develop tools for isolating and characterizing circulating tumor cells. The Vortex VTX-1 instrument harvests intact circulating tumor cells from whole blood samples for use in downstream research and clinical applications such as patient stratification in clinical trials, monitoring disease progression and drug treatment effectiveness. With a mission to enable noninvasive diagnosis of cancer and real-time monitoring throughout a patient’s treatment, Vortex is at the forefront of accelerating cancer research and improving patient outcomes. Vortex is a core subsidiary of NetScientific plc, a transatlantic healthcare technology group with an investment strategy focused on sourcing, funding and commercializing technologies that significantly improve the health and well-being of people with chronic diseases. For more information, visit http://www.vortexbiosciences.com.

Read the full story at http://www.prweb.com/releases/2017/03/prweb14162615.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related medicine news :

1. Vortex Biosciences Selected as Finalist for 2017 SLAS Innovation Award
2. Vortex Biosciences Announces Publication in Oncotarget That Demonstrates the Value of Combining CTCs and cfDNA in Assessing Cancer Patient Disease
3. VeloReality Ups The Ante With New VRide Software For TACX Vortex By Betting On ANT+ FE-C For Multi-Brand, Multi-Rider Resistance Training With Synched HD Video
4. Pipette.com Announces Limited Time Offer of 24% Off List Price on the Vortex-Genie 2
5. BPI Sports Prepares to Launch 1MR VORTEX™ Pre-Workout
6. Pierian Biosciences Names Mark S. Gelder, MD as Chief Medical Officer
7. GD Biosciences Announces Availability of the PULs Cardiac Test in India as Part of International Expansion
8. Wayne State opens new $93 million biosciences center aimed at eliminating health disparities in Detroit
9. Sharp Edge Labs and Creagen Biosciences Enter Drug Discovery Collaboration
10. INDIGO Biosciences Now Offers PXR
11. ACEA Biosciences, Inc. to be featured in Upcoming Episode of Innovations with Ed Begley, Jr.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/25/2019)... ... March 25, 2019 , ... Dr. Kanani, a popular ... implants. , Dr. Kanani ’s dedication to oral surgery has encouraged ... down to $699.00. On top of that, his patients have been known to undergo ...
(Date:3/24/2019)... ... March 24, 2019 , ... Extracting wisdom teeth, those pesky molars that cause pain and swollen ... have wisdom teeth if they wind up being pulled?” Nipomo dentist, Dr. Perry ... , Wisdom teeth, or the third molars, begin to appear between the ages of 17 ...
(Date:3/23/2019)... ... March 22, 2019 , ... ... solutions, is celebrating 17 years of business and transformed lives with the limited-edition ... Rico, and Canada while supplies last, the meal replacement protein shake features sprinkles ...
(Date:3/20/2019)... BIRMINGHAM, Ala. (PRWEB) , ... March 20, 2019 , ... ... care has partnered with ApplePie Capital to offer new and existing franchisees access to ... , Over the past 36 years, AFC has pioneered the concept of urgent ...
(Date:3/20/2019)... CITY, N.J. (PRWEB) , ... March 20, 2019 , ... ... Texas Regional Healthcare Information Management Systems Society (HIMSS) conference in Austin, Texas on March ... GRM’s booth (#523) to learn more about GRM’s healthcare information management solutions . ...
Breaking Medicine News(10 mins):
(Date:3/24/2019)... (PRWEB) , ... March 24, 2019 , ... “I’m seeing the reason I come to ... video series from California Casualty , titled, A Day with Law Enforcement. , ... – spending a day meeting and riding with police officers. The moving videos show the ...
(Date:3/20/2019)... ... March 20, 2019 , ... ... and state public health agencies, today announced the appointment of Retired U.S. Army ... of professional consulting and contracts management experience supporting Federal clients, Davidson will oversee ...
(Date:3/20/2019)... ... March 20, 2019 , ... “Some years ago, when I was ... in Canada in preparing our military athletes for the annual competitions of the International ... I know also that today biofeedback is used to help servicemen prepare for battle ...
Breaking Medicine Technology: